Renaissance Technologies - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 3 filers reported holding TG THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,507
-13.6%
1,376,462
+156.7%
0.02%
+5.3%
Q2 2023$13,319
+1036.4%
536,200
+441.1%
0.02%
+850.0%
Q4 2022$1,172
-99.9%
99,100
-44.7%
0.00%0.0%
Q3 2022$1,061,000
-78.9%
179,200
-84.8%
0.00%
-66.7%
Q2 2022$5,020,000
+167.2%
1,181,100
+497.7%
0.01%
+200.0%
Q1 2022$1,879,000
-60.3%
197,600
-20.7%
0.00%
-66.7%
Q4 2021$4,735,000
-16.3%
249,200
+70.9%
0.01%
-14.3%
Q2 2021$5,656,000
-12.4%
145,800
+8.8%
0.01%
-12.5%
Q1 2021$6,459,000
-66.3%
134,000
-63.6%
0.01%
-61.9%
Q4 2020$19,143,000
+625.4%
368,000
+273.2%
0.02%
+600.0%
Q3 2020$2,639,000
-88.3%
98,600
-91.5%
0.00%
-84.2%
Q2 2020$22,507,000
+346.9%
1,155,400
+125.8%
0.02%
+280.0%
Q1 2020$5,036,000
-61.5%
511,800
-56.6%
0.01%
-50.0%
Q4 2019$13,092,000
+2042.7%
1,179,500
+984.2%
0.01%
+900.0%
Q3 2019$611,000
-56.0%
108,794
-32.2%
0.00%0.0%
Q2 2019$1,388,000
+274.1%
160,500
+248.2%
0.00%
Q1 2019$371,000
-89.7%
46,100
-94.7%
0.00%
-100.0%
Q4 2018$3,591,000
+81.9%
875,900
+148.5%
0.00%
+100.0%
Q3 2018$1,974,000
+558.0%
352,500
+1717.1%
0.00%
+100.0%
Q1 2015$300,000
-88.0%
19,399
-87.7%
0.00%
-83.3%
Q4 2014$2,501,000
+2001.7%
157,881
+1309.8%
0.01%
Q3 2014$119,00011,1990.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 5,229,619$74,261,0003.55%
RA Capital Management 2,472,344$35,107,0002.69%
SENZAR ASSET MANAGEMENT, LLC 475,918$6,758,0002.13%
BRIDGER MANAGEMENT, LLC 2,373,920$33,710,0002.04%
Opaleye Management Inc. 274,200$3,893,0001.11%
Virtus ETF Advisers LLC 89,920$1,277,0001.11%
Eversept Partners, LP 150,000$2,130,0000.99%
Ghost Tree Capital, LLC 300,000$4,260,0000.86%
PURA VIDA INVESTMENTS, LLC 50,000$710,0000.42%
HIGHLAND CAPITAL MANAGEMENT LP 464,391$6,595,0000.34%
View complete list of TG THERAPEUTICS INC shareholders